Atrás
Rango del Día
$10.74
$11.27
Rango de 52 Semanas
$3.90
$14.93
Volumen
855,221
Promedio 50D / 200D
$11.52
/
$10.97
Cierre Anterior
$11.13
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -8.6 | 0.3 |
| P/B | 2.9 | 2.9 |
| ROE % | -41.3 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$21.75
+95.9%
Low: $15.00
High: $25.00
EPS Futuro
-$1.40
Ingresos Est.
8.2 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
-$0.37
-$0.37 – -$0.37
|
260 M | 2 |
| FY2029 |
-$1.72
-$1.72 – -$1.72
|
73 M | 4 |
| FY2028 |
-$1.64
-$1.99 – -$1.19
|
11 M | 6 |
Puntos Clave
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -114.08M
PEG of 0.28 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-41.27%
ROIC-27.09%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.03
Current Ratio14.13
Interest Coverage0.00
Valoración
P/E Ratio
-8.60
P/B Ratio2.90
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -129.47M |
| ROE | -41.27% | ROA | -31.50% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -114.08M |
| ROIC | -27.09% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 14.13 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -8.60 | P/B Ratio | 2.90 |
| P/S Ratio | N/A | PEG Ratio | 0.28 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.11B | Enterprise Value | 1.08B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -129.47M | -127.85M | -100.70M | -89.12M | -78.72M |
| EPS (Diluted) | -1.47 | -1.83 | -1.96 | -2.25 | -2.07 |
| Gross Profit | -1.22M | -1.11M | -1.03M | 0.0 | 0.0 |
| Operating Income | -143.00M | -142.90M | -110.78M | -91.77M | -78.87M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 411.00M | 274.14M | 254.69M | 250.36M | 298.64M |
| Total Liabilities | 26.64M | 31.02M | 30.60M | 28.01M | 25.67M |
| Shareholders' Equity | 384.36M | 243.12M | 224.09M | 222.35M | 272.98M |
| Total Debt | 11.55M | 3.18M | 10.21M | 12.10M | 1.93M |
| Cash & Equivalents | 45.67M | 59.41M | 23.38M | 66.84M | 226.01M |
| Current Assets | 288.47M | 262.25M | 212.60M | 210.46M | 240.52M |
| Current Liabilities | 20.42M | 24.85M | 20.46M | 15.39M | 15.15M |